Abstract

BackgroundWhether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D(XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. Therefore, we conducted this meta-analysis to systematically assess the possible association between them.MethodsThe OVID, Medline, Embase, Pubmed, Web of Science databases were searched to identify the eligible studies. The odds ratio (OR) with 95% confidence interval (95% CI) were used to assess the strength of association.ResultsA total of 11,443 subjects from eighteen studies were subjected to meta-analysis. Overall, XPD Lys751Gln polymorphism had no association with increased HNC risk under all five genetic models (P > 0.05). In the subgroup analysis by ethnicity and source of controls, still no significant association was found under five genetic models (P > 0.05). In the subgroup analysis by cancer type, XPD Lys751Gln polymorphism had statistically significant association with elevated laryngeal cancer (LC) and nasopharyngeal cancer (NPC) risk under heterozygous comparison and dominant model (P<0.05) and borderline significantly increased risk was found under allele contrast for LC and NPC. Carriers of Lys allele and Lys/Lys genotype may be associated with elevated LC and NPC risk.ConclusionsThere is overall lack of association between XPD Lys751Gln polymorphism and HNC risk under all five genetic models and still no significant association was found in the subgroup analysis by ethnicity and source of controls. However, XPD Lys751Gln polymorphism was significantly associated with susceptibility to LC and NPC and the Lys allele and Lys/Lys genotype of XPD Lys751Gln polymorphism may be a risk factor for LC and NPC. However, relatively modest sample sizes were included in this meta-analysis and studies with large sample sizes and representative population are warranted to further clarify this finding.Virtual slidesThe virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5628716106316015.

Highlights

  • Head and neck cancers (HNC) which involve malignant neoplasms of the oral cavity, pharynx, and larynx, are the sixth most common cancers threatening human life worldwide [1]

  • Three papers [17-19] were excluded due to the genotype frequencies of control group being inconsistent with Hardy– Weinberg equilibrium (HWE) and one paper [20] was ruled out for the study was focusing on premalignant lesion instead of cancer

  • In the subgroup analysis by cancer type, xeroderma pigmentosum group D (XPD) Lys7 51Gln polymorphism had statistically significant association with elevated laryngeal cancer (LC) and nasopharyngeal cancer (NPC) risk under heterozygous comparison and dominant model (P < 0.05, Figure 3, Table 2) and borderline significantly increased risk was found under allele contrast for LC (OR =0.82, 95% Confidence interval (CI) = 0.67-1.00, P = 0.056) and NPC (OR =0.60, 95% confidence interval (95% CI) =0.36-1.00, P = 0.05)

Read more

Summary

Introduction

Head and neck cancers (HNC) which involve malignant neoplasms of the oral cavity, pharynx, and larynx, are the sixth most common cancers threatening human life worldwide [1]. A series of case–control studies have been conducted to clarify the association between XPD Lys751Gln polymorphism and HNC risk. We performed this meta-analysis in order to precisely assess the possible association of XPD Lys751Gln with the susceptibility to develop HNC. Whether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D (XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. We conducted this meta-analysis to systematically assess the possible association between them

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call